search results for 
Logo

Fresenius SE & Co. KGaA
Consolidated segment reporting

BY BUSINESS SEGMENT


Fresenius Medical CareFresenius KabiFresenius HeliosFresenius VamedCorporate / OtherFresenius Group
€ in millions201320121Change201322012Change20132012Change20132012Change2013320124Change20132012Change
Sales11,00010,7412%4,9964,53910%3,3933,2006%1,02084621%-78-36-117%20,33119,2905%
thereof contribution to consolidated sales10,97810,7242%4,9564,48910%3,3933,2006%98784617%1731-45%20,33119,2905%
thereof intercompany sales221729%4050-20%0033----95-67-42%00
contribution to consolidated sales54%56%24%23%17%17%5%4%0%0%100%100%
EBITDA2,1872,282-4%1,1431,1014%50843218%655910%-69-11540%3,8343,7592%
Depreciation and amortization4884694%21716730%1181107%10825%1022-55%8437769%
EBIT1,6991,813-6%926934-1%39032221%55518%-79-13742%2,9912,9830%
Net interest-308-3327%-236-28617%-48-6728%-3-1-200%1120-45%-584-66612%
Income taxes-446-50211%-178-166-7%-60-42-43%-14-140%2965-55%-669-659-2%
Net income attributable to shareholders of Fresenius SE & Co. KGaA836870-4%48744410%27520335%37356%-624-6260%1,0119269%
                   
Operating cash flow1,5321,587-3%488596-18%2582408%3135-11%11-20155%2,3202,438-5%
Cash flow before acquisitions and dividends9841,069-8%177357-50%916932%2024-17%1-33103%1,2731,486-14%
                   
Total assets16,76416,921-1%8,5988,662-1%6,5974,40850%7266767%73-3--32,75830,6647%
Debt6,1036,290-3%4,7354,964-5%3,5381,293174%1177458%-1,689-1,593-6%12,80411,02816%
Capital expenditure, gross5635267%31727615%172180-4%11110%1014-29%1,0731,0077%
Acquisitions, gross / investments4241,408-70%131877-85%2,185579--1644-64%-2264-101%2,7543,172-13%
                   
Research and development expenses95879%25019429%----00324-88%34830514%
Employees (per capita on balance sheet date)95,63790,8665%31,96130,2146%42,91342,8810%7,0104,43258%816931-12%178,337169,3245%
                   
Key figures
EBITDA margin19.9%21.2%22.9%24.3%15.0%13.5%6.4%7.0%19.1% 220.0% 6
EBIT margin15.4%16.9%18.5%20.6%11.5%10.1%5.4%6.0%15.0% 215.9% 6
Depreciation and amortization in % of sales4.4%4.4%4.3%3.7%3.5%3.4%1.0%0.9%4.1%4.0%
Operating cash flow in % of sales13.9%14.8%9.8%13.1%7.6%7.5%3.0%4.1%11.4%12.6%
ROOA10.5%11.4%11.9%12.3%9.3%8.2%11.6%12.8%10.6% 511.0% 7

Fresenius Medical CareFresenius KabiFresenius HeliosFresenius VamedCorporate / OtherFresenius Group
€ in millions201320121Change201322012Change20132012Change20132012Change2013320124Change20132012Change
Sales11,00010,7412%4,9964,53910%3,3933,2006%1,02084621%-78-36-117%20,33119,2905%
thereof contribution to consolidated sales10,97810,7242%4,9564,48910%3,3933,2006%98784617%1731-45%20,33119,2905%
thereof intercompany sales221729%4050-20%0033----95-67-42%00
contribution to consolidated sales54%56%24%23%17%17%5%4%0%0%100%100%
EBITDA2,1872,282-4%1,1431,1014%50843218%655910%-69-11540%3,8343,7592%
Depreciation and amortization4884694%21716730%1181107%10825%1022-55%8437769%
EBIT1,6991,813-6%926934-1%39032221%55518%-79-13742%2,9912,9830%
Net interest-308-3327%-236-28617%-48-6728%-3-1-200%1120-45%-584-66612%
Income taxes-446-50211%-178-166-7%-60-42-43%-14-140%2965-55%-669-659-2%
Net income attributable to shareholders of Fresenius SE & Co. KGaA836870-4%48744410%27520335%37356%-624-6260%1,0119269%
                   
Operating cash flow1,5321,587-3%488596-18%2582408%3135-11%11-20155%2,3202,438-5%
Cash flow before acquisitions and dividends9841,069-8%177357-50%916932%2024-17%1-33103%1,2731,486-14%
                   
Total assets16,76416,921-1%8,5988,662-1%6,5974,40850%7266767%73-3--32,75830,6647%
Debt6,1036,290-3%4,7354,964-5%3,5381,293174%1177458%-1,689-1,593-6%12,80411,02816%
Capital expenditure, gross5635267%31727615%172180-4%11110%1014-29%1,0731,0077%
Acquisitions, gross / investments4241,408-70%131877-85%2,185579--1644-64%-2264-101%2,7543,172-13%
                   
Research and development expenses95879%25019429%----00324-88%34830514%
Employees (per capita on balance sheet date)95,63790,8665%31,96130,2146%42,91342,8810%7,0104,43258%816931-12%178,337169,3245%
                   
Key figures
EBITDA margin19.9%21.2%22.9%24.3%15.0%13.5%6.4%7.0%19.1% 220.0% 6
EBIT margin15.4%16.9%18.5%20.6%11.5%10.1%5.4%6.0%15.0% 215.9% 6
Depreciation and amortization in % of sales4.4%4.4%4.3%3.7%3.5%3.4%1.0%0.9%4.1%4.0%
Operating cash flow in % of sales13.9%14.8%9.8%13.1%7.6%7.5%3.0%4.1%11.4%12.6%
ROOA10.5%11.4%11.9%12.3%9.3%8.2%11.6%12.8%10.6% 511.0% 7

The consolidated segment reporting by business segment is an integral part of the notes. The following notes are an integral part of the consolidated financial statements

BY REGION


€ in millionsEuropeNorth AmericaAsia-PacificLatin AmericaAfricaFresenius Group
 20132012Change20132012Change20132012Change20132012Change20132012Change20132012Change
Sales8,2167,7975%8,6208,1446%1,9451,8992%1,1741,1264%37632416%20,33119,2905%
contribution to consolidated sales40%40%42%42%10%10%6%6%2%2%100%100%
EBIT82374610%1,6671,700-2%296321-8%1591581%4658-21%2,9912,9830%
Depreciation and amortization3703574%37732815%56528%35336%56-17%8437769%
                   
Total assets13,52911,08922%15,83316,424-4%2,3052,08511%9509292%1411373%32,75830,6647%
Capital expenditure, gross519532-2%37232614%1118334%62595%9729%1,0731,0077%
Acquisitions, gross / investments2,257914147%3472,238-84%12611--219133%3---2,7543,172-13%
                   
Employees (per capita on balance sheet date)85,70681,7775%60,60058,2644%15,85914,31511%14,47413,4857%1,6981,48314%178,337169,3245%

€ in millionsEuropeNorth AmericaAsia-PacificLatin AmericaAfricaFresenius Group
 20132012Change20132012Change20132012Change20132012Change20132012Change20132012Change
Sales8,2167,7975%8,6208,1446%1,9451,8992%1,1741,1264%37632416%20,33119,2905%
contribution to consolidated sales40%40%42%42%10%10%6%6%2%2%100%100%
EBIT82374610%1,6671,700-2%296321-8%1591581%4658-21%2,9912,9830%
Depreciation and amortization3703574%37732815%56528%35336%56-17%8437769%
                   
Total assets13,52911,08922%15,83316,424-4%2,3052,08511%9509292%1411373%32,75830,6647%
Capital expenditure, gross519532-2%37232614%1118334%62595%9729%1,0731,0077%
Acquisitions, gross / investments2,257914147%3472,238-84%12611--219133%3---2,7543,172-13%
                   
Employees (per capita on balance sheet date)85,70681,7775%60,60058,2644%15,85914,31511%14,47413,4857%1,6981,48314%178,337169,3245%

The consolidated segment reporting by region is an integral part of the notes. The following notes are an integral part of the consolidated financial statements.

Continue reading:
Notes